Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

As interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave stateside with plans for a new commercial manufacturing ...

Analyst Insight: Cell and gene therapies (CGT) provide highly personalized solutions for previously incurable genetic conditions and chronic diseases. While allogeneic CGT relies on a source of cells ...

Partners Have Successfully Revitalized Companies in a Wide Range of Industries CHICAGO, Feb. 4, 2025 /PRNewswire/ -- Whitebridge Capital Partners, LLC, is seeking commercial and industrial ...

BEND, Ore.--(BUSINESS WIRE)--Serán Bioscience (“Serán” or “the Company”), a leading contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 ...

BOCA RATON, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or “the Company”), a clinical-stage inflammation and immunology company focused on developing treatments ...

Data centers have complex mechanical and electrical designs with unique performance and reliability needs. Unique BMS and approaches are required in order to optimize the control, monitoring, and ...